Details

NameSymbolSector
ALIVUS LIFE SCIENCES LIMITEDALIVUSPharmaceuticals
Open
1055
High
1069.9
Low
1047.2
Close
1051.2
Volume
104156
Exchange
nse
Time
15-Jun-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Alivus Life Sciences is  
Short Line
Estimated Stoploss of Alivus Life Sciences is ₹  
1069.9
Alivus Life Sciences has a  
Bearishℹ
 pattern. 
Formation of  
Short Line
 candle pattern indicates the trend direction of Alivus Life Sciences is  
Unpredictableℹ
. 

Trend

Alivus Life Sciences is in  
Sideways trendℹ
. 
Price of Alivus Life Sciences is  
Upℹ
 by  

0.03

%. 
Target
Buy @ 

931.65

Sell @ 

1135.11

Current @ 

1051.2

Volume

The trade volumes of Alivus Life Sciences have been  
Underperformingℹ
Though the volume trend for Alivus Life Sciences appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Alivus Life Sciences is  

Up

 by  

1.64

% 

Valuation

The current market price of Alivus Life Sciences is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3411cr and total assets worth ₹ 3411cr, the balance sheet of Alivus Life Sciences is:  
Balancedℹ
. 
Cashflow
Alivus Life Sciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 230cr

. It is  
Downℹ
 by  

1452.94

%. 

(*Mar 2025)

38.64% i.e. ₹ 391cr earned in operatingℹ
60.77% i.e. ₹ 615cr spent in investingℹ
0.59% i.e. ₹ 6cr spent in financingℹ
0% in otherℹ
Alivus Life Sciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 17cr

. It is  
Upℹ
 by  

107.46

%. 

(*Mar 2024)

51.11% i.e. ₹ 413cr earned in operatingℹ
14.36% i.e. ₹ 116cr spent in investingℹ
34.53% i.e. ₹ 279cr spent in financingℹ
0% in otherℹ
Income
The income of Alivus Life Sciences is  

₹ 602cr

 and  

Profit

 is :  

₹ 130cr

(*Sep 2025)

Alivus Life Sciences Profit is down by:  

14.18

% and Income is Down by:  

7.44

% 

(*Sep 2025)

The income of Alivus Life Sciences is  

₹ 610cr

 and  

Profit

 is :  

₹ 121cr

(*Jun 2025)

Alivus Life Sciences Profit is up by:  

3.68

% and Income is Up by:  

1.07

% 

(*Jun 2025)

The income of Alivus Life Sciences is  

₹ 659cr

 and  

Profit

 is :  

₹ 141cr

(*Mar 2025)

Alivus Life Sciences Profit is up by:  

43.16

% and Income is Up by:  

26.6

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.